YK: Data curation, Formal analysis, Writing review & editing, Funding acquisition
Patients with obesity-related heart failure, particularly HFpEF, who experience symptoms like breathlessness and reduced exercise capacity, may also benefit as emerging evidence suggests these therapies can improve symptoms and quality of life.Who should avoid them or exercise caution before use
68 measured GSH concentrations in 33 people between 60 and 79 years of age, and related the data to health, the number of illnesses, and other risk factors for chronic disease
Tirzepatide also reduces liver fat, with studies showing meaningful improvements, but the magnitude does not approach what retatrutide achieves
Patients often exhibit structurally abnormal, swollen mitochondria with disrupted cristae, impaired mitochondrial recycling (a process called mitophagy), and chronically elevated levels of reactive oxygen species
Biomater Sci